Federated Hermes Portfolio holdings
Federated Hermes is an investment manager that runs mutual funds, ETFs and other portfolios across stocks, bonds, alternative and private markets and liquidity management. It began in 1955 as Federated Investors, set up by three high school classmates: John F. Donahue, Thomas J. Donnelly and Richard B. Fisher. In 2018 the firm bought a majority stake in Hermes Fund Managers, which ran Hermes Investment Management, from the BT Pension Scheme. In 2020 Federated Investors renamed itself Federated Hermes. Its clients include corporations, government entities, insurance companies, foundations, endowments, banks and brokerages.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$436M |
| 2 |
Regions Financial
RF
|
+$313M |
| 3 |
Automatic Data Processing
ADP
|
+$289M |
| 4 |
Intuit
INTU
|
+$288M |
| 5 |
Netflix
NFLX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 2 |
Teradyne
TER
|
+$320M |
| 3 |
Truist Financial
TFC
|
+$313M |
| 4 |
UnitedHealth
UNH
|
+$287M |
| 5 |
Huntington Bancshares
HBAN
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.03% |
| 2 | Healthcare | 13.59% |
| 3 | Industrials | 13.09% |
| 4 | Financials | 10.33% |
| 5 | Consumer Discretionary | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
526
Teladoc Health
TDOC
$1.55B
| $18M | 0.03% |
2,127,008
+422,482
| +25% | +$2.81M |
2018 Q3
31 quarters
|
|
527
RXO
RXO
$4.53B
| $18M | 0.03% |
+653,467
| New | +$14.4M |
2026 Q2
0 quarters
|
|
528
Liftoff Mobile
LFTO
$2.5B
| $18M | 0.03% |
+750,000
| New | +$19.4M |
2026 Q2
0 quarters
|
|
529
Compass Minerals
CMP
$979M
| $17.9M | 0.03% |
574,763
+36,134
| +7% | +$1.02M |
2025 Q1
5 quarters
|
|
530
Lumen Technologies, Inc. Common Stock
LUMN
$5.03B
| $17.8M | 0.03% |
2,320,790
-557,682
| -19% | -$4.89M |
2013 Q2
52 quarters
|
|
531
Pitney Bowes
PBI
$2.21B
| $17.8M | 0.03% |
1,015,780
+170,145
| +20% | +$2.6M |
2013 Q2
52 quarters
|
|
532
Cipher Digital
CIFR
$3.03B
| $17.7M | 0.03% |
723,373
+281,574
| +64% | +$5.94M |
2024 Q4
6 quarters
|
|
533
Chubb
CB
$139B
| $17.7M | 0.03% |
51,863
-109,942
| -68% | -$35.9M |
2013 Q2
52 quarters
|
|
534
Cboe Global Markets
CBOE
$35B
| $17.6M | 0.03% |
72,496
+6,212
| +9% | +$1.9M |
2018 Q4
30 quarters
|
|
535
SGHC Ltd
SGHC
$5.43B
| $17.5M | 0.03% |
1,289,688
+485,419
| +60% | +$6.15M |
2025 Q2
4 quarters
|
|
536
Pinnacle West Capital
PNW
$12.9B
| $17.4M | 0.03% |
162,840
-105
| -0.1% | -$10.7K |
2013 Q2
52 quarters
|
|
537
Essential Properties Realty Trust
EPRT
$5.89B
| $17.4M | 0.03% |
583,353
+97,098
| +20% | +$3.02M |
2023 Q4
10 quarters
|
|
538
Wells Fargo
WFC
$250B
| $17.2M | 0.02% |
208,280
-81,801
| -28% | -$6.57M |
2013 Q2
52 quarters
|
|
539
MGP Ingredients
MGPI
$367M
| $17.2M | 0.02% |
980,092
-213,668
| -18% | -$3.89M |
2024 Q4
6 quarters
|
|
540
Revolution Medicines
RVMD
$41B
| $17M | 0.02% |
+90,878
| New | +$13.3M |
2026 Q2
0 quarters
|
|
541
AMN Healthcare
AMN
$1.82B
| $17M | 0.02% |
525,781
-40,389
| -7% | -$1.04M |
2013 Q2
52 quarters
|
|
542
UGI
UGI
$8.29B
| $17M | 0.02% |
492,570
-1,477,953
| -75% | -$52.2M |
2013 Q2
52 quarters
|
|
543
F5
FFIV
$19.2B
| $16.8M | 0.02% |
40,466
-66,758
| -62% | -$23.7M |
2013 Q2
52 quarters
|
|
544
Karman Holdings
KRMN
$5.29B
| $16.7M | 0.02% |
335,450
-894,206
| -73% | -$57.8M |
2025 Q3
3 quarters
|
|
545
Dover
DOV
$27.6B
| $16.7M | 0.02% |
74,544
+4,998
| +7% | +$1.09M |
2013 Q2
52 quarters
|
|
546
Allegro MicroSystems
ALGM
$5.69B
| $16.5M | 0.02% |
237,367
+227,499
| +2,305% | +$10.6M |
2020 Q4
22 quarters
|
|
547
Coursera
COUR
$917M
| $16.5M | 0.02% |
2,925,859
+1,390,208
| +91% | +$7.9M |
2023 Q3
11 quarters
|
|
548
Krystal Biotech
KRYS
$9.8B
| $16.3M | 0.02% |
43,848
+8,353
| +24% | +$2.5M |
2024 Q3
7 quarters
|
|
549
Talos Energy
TALO
$3.04B
| $16.2M | 0.02% |
1,251,927
+248,256
| +25% | +$3.7M |
2025 Q3
3 quarters
|
|
550
Sagimet Biosciences
SGMT
$703M
| $16.1M | 0.02% |
2,086,715
+2,085,934
| +267,085% | +$14.2M |
2025 Q3
3 quarters
|
|
Similar funds
Federated Hermes's Q2 2026 Portfolio in Review
As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
- Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
- Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
- Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
- Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
- Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
- Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.